InsiderClue
Stocks · Health care · Services-Offices & Clinics of Doctors of Medicine

Basel Medical Group Ltd

BMGL Clue Score40
Singapore Fiscal year ends June CIK 0002004489
$3.85 +3.77% Close, 13 Oct 2026
Alert on the numbers Alert on insider trades
Price $3.85 +153.29% Close, 13 Oct 2026

Closing prices at the end of each trading day, from 25 Feb 2025. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
RevenueNet income
Fiscal year 2024Revenue10.1Net income2.1EPS, diluted0.13Fiscal year 2025Revenue11.3 +12.6%Net income−10.6 −613.1%EPS, diluted−0.57 −538.5%
FY2024FY2025
Revenue 10.1 11.3
Growth +12.6%
Net income 2.1 −10.6
Growth −613.1%
EPS, diluted 0.13 −0.57
Growth −538.5%

Margins

How much of each dollar of revenue it keeps. Point at a year for the detail.
Net margin
Fiscal year 2024Net margin20.6%Free cash flow margin24.9%Fiscal year 2025Net margin−94.0%Free cash flow margin−40.6%
FY2024FY2025
Net margin 20.6% −94.0%
Free cash flow margin 24.9% −40.6%

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2024Operating cash flow2.5Capital expenditure−0.0Free cash flow2.5Fiscal year 2025Operating cash flow−4.0Capital expenditure−0.6Free cash flow−4.6 −283.9%
FY2024FY2025
Operating cash flow 2.5 −4.0
Capital expenditure −0.0 −0.6
Free cash flow 2.5 −4.6
Growth −283.9%

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash and securitiesTotal debt
Fiscal year 2024Cash and securities2.0Total debt4.3Net cash (debt)−2.3Shareholders’ equity7.6Debt to equity0.57Fiscal year 2025Cash and securities3.0Total debt5.1Net cash (debt)−2.0Shareholders’ equity5.4Debt to equity0.93
FY2024FY2025
Cash and securities 2.0 3.0
Total debt 4.3 5.1
Net cash (debt) −2.3 −2.0
Shareholders’ equity 7.6 5.4
Debt to equity 0.57 0.93

In millions of SGD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Cash flow

In millions of SGD, except per-share figures; shares in millions. Fiscal years ending June, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2024 30 Jun 2024 FY2025 30 Jun 2025
Operations
2.5 −4.0
Growth −261.2%
Investment
−0.0 −0.6
calc 2.5 −4.6
Growth −283.9%
calc 0.15 −0.24
−0.0 −10.9
Financing
−1.8 16.5

Lines marked calc are worked out here from filed figures; point at one for how. Capital expenditure, dividends and buybacks are shown as money out, so negative. Shown in SGD as filed; the screener converts to dollars.